Management of side effects of BCR/ABL-negative chronic myeloproliferative neoplasm therapies. Focus on anagrelide.
| Image |  |
|---|---|
| Description | scientific article published on 14 September 2015 |
| Author/s |
author: Natalia de las Heras |
| Publication date | September 14, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |